Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Deubiquitnase BAP1 Downregulation in Myeloid Malignances: A New Pathogenic Mechanism, Dominant in Chronic Myelomonocytic Leukemia

Ana Maria Hurtado, Eva Caparrós, Jose Miguel Torregrosa, Ginés Luengo, Mara Toderici, María Eugenia De la Morena, Begoña Muiña, Maria Luisa Lozano, Constant Martinez, Mari Luz Amigo, Felipe De Arriba, Francisco Ortuño, Raul Teruel Montoya, PhD, Francisca Ferrer-Marin, MD, PhD, Vicente Vicente, MD PhD, Andres Jerez, MD PhD

Blood (2014) 124 (21): 5594.

https://doi.org/10.1182/blood.V124.21.5594.5594

Published: 2014

Journal Articles

Anticipating High-Risk Chromosome Clonal Evolution in Chronic Lymphocytic Leukemia: A Next Generation Sequencing and Longitudinal FISH Combined Study

Ana Maria Hurtado, Chahinez Hamedi, Bartlomiej P Przychodzen, Ana I. Anton, Maria Dolores Garcia-Malo, Gloria Soler, Felipe De Arriba, Francisco Ortuño, Raul Teruel Montoya, PhD, Jaroslaw P. Maciejewski, MD PhD, Vicente Vicente, MD PhD, Andres Jerez, MD PhD

Blood (2014) 124 (21): 3305.

https://doi.org/10.1182/blood.V124.21.3305.3305

Published: 2014

Journal Articles

Deletion Of Tifab, a Novel Candidate Gene On Chromosome 5q, Results In Hematopoietic Defects By Changing The Dynamic Range Of Innate Immune Pathway Activation

Melinda Varney, PhD, Susanne Christie, Madeline Niederkorn, Jing Fang, MD, PhD, Andres Jerez, MD, PhD, Jaroslaw P. Maciejewski, MD, PhD, FACP, Jun-ichiro Inoue, PhD, Daniel T Starczynowski, PhD

Blood (2013) 122 (21): 102.

https://doi.org/10.1182/blood.V122.21.102.102

Published: 2013

Journal Articles

SQSTM1/p62 Is a Necessary Cofactor In MDS/AML With Deletion Of Mir-146a

Jing Fang, MD/PhD, Brenden Barker, BSc, Lyndsey Bolanos, BSc, Xiaona Liu, BSc, Andres Jerez, MD, PhD, Hideki Makishima, MD, PhD, Dinesh S. Rao, M.D., James C. Mulloy, PhD, Jaroslaw P. Maciejewski, MD, PhD, Jose A. Cancelas, M.D. PhD., Daniel T Starczynowski, PhD

Blood (2013) 122 (21): 747.

https://doi.org/10.1182/blood.V122.21.747.747

Published: 2013

Journal Articles

Mutational Spectrum of Myelodysplastic Syndrome Malignancies Revealed by Whole Exome Sequencing

Inés Gómez-Seguí, MD, Bartlomiej P Przychodzen, Kenichi Yoshida, MD, Matthew Ruffalo, Andres Jerez, MD, PhD, Hideki Makishima, MD, PhD, Satoru Miyano, PhD, Yuichi Shiraishi, Holleh D Husseinzadeh, MD, Edward P Evans, Naoko Hosono, MD, PhD, Kathryn M Guinta, Thomas LaFramboise, PhD, Seishi Ogawa, MD, PhD, Yogen Saunthararajah, MD, Mikkael A. Sekeres, MD, MS, Jaroslaw P. Maciejewski, MD, PhD

Blood (2012) 120 (21): 307.

https://doi.org/10.1182/blood.V120.21.307.307

Published: 2012

Journal Articles

Association of MDM2 G ene Polymorphisms SNP285 and 309 with Myelodysplastic Syndromes (MDS) Susceptibility and Outcome.

Blood (2012) 120 (21): 2823.

https://doi.org/10.1182/blood.V120.21.2823.2823

Published: 2012

Journal Articles

Mutation Screening Associated with Chromosome 7 Abnormalities Using Next Generation Whole Exome Sequencing

Naoko Hosono, MD, PhD, Hideki Makishima, MD, PhD, Andres Jerez, MD, PhD, Ines Gomez-Segui, MD, Bartlomiej Przychodzen, BS, Mikkael A. Sekeres, MD, MS, Satoru Miyano, PhD, Yuichi Shiraishi, PhD, Seishi Ogawa, MD, PhD, Jaroslaw P. Maciejewski, MD, PhD

Blood (2012) 120 (21): 173.

https://doi.org/10.1182/blood.V120.21.173.173

Published: 2012

Journal Articles

Whole Exome Sequencing to Predict Response to Hypomethylating Agents in MDS

Blood (2012) 120 (21): 1698.

https://doi.org/10.1182/blood.V120.21.1698.1698

Published: 2012

Journal Articles

Downstream Consequences of U2AF1 Mutations in MDS Are a Result of a Specific Misplicing Patterns Due to Faulty Recognition of 3'acceptor Splice Site

Bartlomiej P Przychodzen, Hideki Makishima, Andres Jerez, MD, PhD, Richard A Padgett, PhD, Jaroslaw P. Maciejewski, MD, PhD

Blood (2012) 120 (21): 3517.

https://doi.org/10.1182/blood.V120.21.3517.3517

Published: 2012

Journal Articles

Identifying Immunogenetic Features That Distinguish Immune Mediated, Immunosuppression-Sensitive Disease in Aplastic Anemia (AA)

Manuel G. Afable, II, MD, Theresa Guo, MD, Bartlomiej P Przychodzen, Lisa Rybicki, MS, Michael J. Clemente, Andres Jerez, MD, PhD, Holleh D Husseinzadeh, MD;, Edward P Evans, Alan E. Lichtin, MD, Aleksandra Wodnar-Filipowicz, PhD, Mikkael A. Sekeres, MD, MS, Jaroslaw P. Maciejewski, MD, PhD

Blood (2012) 120 (21): 3481.

https://doi.org/10.1182/blood.V120.21.3481.3481

Published: 2012

Journal Articles

STAT3-Mutations Indicate the Presence of Subclinical Self-Reactive Cytotoxic T Cell Clones in Aplastic Anemia and Myelodysplastic Syndromes

Blood (2012) 120 (21): 646.

https://doi.org/10.1182/blood.V120.21.646.646

Published: 2012

Journal Articles

Pathway Analysis of Molecular Mutations Can Modify Morphologic, Cytogenetic and Prognostic Risk Stratification Schemes in Myelodysplastic Syndromes (MDS), Myelodysplastic Syndromes/Myeloproliferative Neoplasms (MDS/MPN), and Secondary Acute Myeloid Leukemia (AML)

Edy Hasrouni, Valeria Visconte, PhD, Ali Tabarroki, MD, Heesun J. Rogers, MD, PhD, Fabiola Traina, MD, PhD, Anna Jankowska, MSC, Yang Liu, Betty K. Hamilton, MD, Manoj Bupathi, MD, Hideki Makishima, MD, PhD, Andres Jerez, MD, PhD, Edward A. Copelan, MD, Anjali Advani, MD, Michael A McDevitt, MD, PhD, Matt Kalaycio, MD, Yogen Saunthararajah, MD, Mikkael A. Sekeres, MD, MS, Jaroslaw P. Maciejewski, MD, PhD, Ramon V. Tiu, MD

Blood (2012) 120 (21): 3791.

https://doi.org/10.1182/blood.V120.21.3791.3791

Published: 2012

Journal Articles

Somatic PTPRT and ANGPT2 Mutations in Large Granulocyte Leukemia

Emma I Andersson, MSc, Samuli Eldfors, MSc, Hanna L M Koskela, MD, Pekka Ellonen, MSc, Thomas Olson, BSc, Andres Jerez, MD, PhD, Michael J. Clemente, Olli Kallioniemi, MD, PhD, Kimmo Porkka, MD, PhD, Thomas P. Loughran, Jr., M.D., Jaroslaw P. Maciejewski, MD, PhD, Caroline Heckman, PhD, Satu Mustjoki, MD, PhD

Blood (2012) 120 (21): 1302.

https://doi.org/10.1182/blood.V120.21.1302.1302

Published: 2012

Journal Articles

Haploinsufficiency of Mir-146a in High-Risk Del(5q) MDS/AML Requires an Intrachromosomal Gene Network Involving p62/TRAF6/NF-κB

Jing Fang, MD/PhD, Andres Jerez, MD, PhD, Christopher Rasch, BSc, Lyndsey Bolanos, BSc, Jaroslaw P. Maciejewski, MD, PhD, Daniel T Starczynowski, PhD

Blood (2012) 120 (21): 557.

https://doi.org/10.1182/blood.V120.21.557.557

Published: 2012

Journal Articles

Novel Recurrent Mutations in the Ras -Like GTP-Binding Gene Rit1 in Myeloid Malignancies

Inées Góomez-Seguíi, MD., Hideki Makishima, MD, PhD, Andres Jerez, MD, PhD, Kenichi Yoshida, MD, Bartlomiej P Przychodzen, Satoru Miyano, PhD, Yuichi Shiraishi, Holleh D Husseinzadeh, MD, Edward P Evans, Kathryn M Guinta, Naoko Hosono, MD., PhD., Michael A McDevitt, MD, PhD, Alison R. Moliterno, MD, Mikkael A. Sekeres, MD, MS, Seishi Ogawa, MD, PhD, Jaroslaw P. Maciejewski, MD, PhD

Blood (2012) 120 (21): 558.

https://doi.org/10.1182/blood.V120.21.558.558

Published: 2012

Journal Articles

Discovery of STAT5b Mutations and Small Subclones of STAT3 Mutations in Large Granular Lymphocytic (LGL) Leukemia

Blood (2012) 120 (21): 871.

https://doi.org/10.1182/blood.V120.21.871.871

Published: 2012

Journal Articles

Tifab, a Novel Candidate Gene in Deletion Chromosome 5q, Contributes to Deregulation of NF-κB Signaling in MDS/AML.

Melinda Varney, PhD, Andres Jerez, MD, PhD, Jing Fang, MD/PhD, David Miller, Lyndsey Bolanos, BSc, Aly Karsan, MD, Jaroslaw P. Maciejewski, MD, PhD, Daniel T Starczynowski, PhD

Blood (2012) 120 (21): 2812.

https://doi.org/10.1182/blood.V120.21.2812.2812

Published: 2012

NARROW

Deubiquitnase BAP1 Downregulation in Myeloid Malignances: A New Pathogenic Mechanism, Dominant in Chronic Myelomonocytic Leukemia

Anticipating High-Risk Chromosome Clonal Evolution in Chronic Lymphocytic Leukemia: A Next Generation Sequencing and Longitudinal FISH Combined Study

Deletion Of Tifab, a Novel Candidate Gene On Chromosome 5q, Results In Hematopoietic Defects By Changing The Dynamic Range Of Innate Immune Pathway Activation

SQSTM1/p62 Is a Necessary Cofactor In MDS/AML With Deletion Of Mir-146a

Mutational Spectrum of Myelodysplastic Syndrome Malignancies Revealed by Whole Exome Sequencing

Association of MDM2 G ene Polymorphisms SNP285 and 309 with Myelodysplastic Syndromes (MDS) Susceptibility and Outcome.

Mutation Screening Associated with Chromosome 7 Abnormalities Using Next Generation Whole Exome Sequencing

Whole Exome Sequencing to Predict Response to Hypomethylating Agents in MDS

Downstream Consequences of U2AF1 Mutations in MDS Are a Result of a Specific Misplicing Patterns Due to Faulty Recognition of 3'acceptor Splice Site

Identifying Immunogenetic Features That Distinguish Immune Mediated, Immunosuppression-Sensitive Disease in Aplastic Anemia (AA)

STAT3-Mutations Indicate the Presence of Subclinical Self-Reactive Cytotoxic T Cell Clones in Aplastic Anemia and Myelodysplastic Syndromes

Pathway Analysis of Molecular Mutations Can Modify Morphologic, Cytogenetic and Prognostic Risk Stratification Schemes in Myelodysplastic Syndromes (MDS), Myelodysplastic Syndromes/Myeloproliferative Neoplasms (MDS/MPN), and Secondary Acute Myeloid Leukemia (AML)

Somatic PTPRT and ANGPT2 Mutations in Large Granulocyte Leukemia

Haploinsufficiency of Mir-146a in High-Risk Del(5q) MDS/AML Requires an Intrachromosomal Gene Network Involving p62/TRAF6/NF-κB

Novel Recurrent Mutations in the Ras -Like GTP-Binding Gene Rit1 in Myeloid Malignancies

Discovery of STAT5b Mutations and Small Subclones of STAT3 Mutations in Large Granular Lymphocytic (LGL) Leukemia

Tifab, a Novel Candidate Gene in Deletion Chromosome 5q, Contributes to Deregulation of NF-κB Signaling in MDS/AML.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only